Literature DB >> 25858177

Lung function and respiratory diseases in people with psychosis: population-based study.

Krista Partti1, Tuula Vasankari2, Merja Kanervisto2, Jonna Perälä2, Samuli I Saarni2, Pekka Jousilahti2, Jouko Lönnqvist2, Jaana Suvisaari2.   

Abstract

BACKGROUND: There is little information on lung function and respiratory diseases in people with psychosis. AIMS: To compare the respiratory health of people with psychosis with that of the general population.
METHOD: In a nationally representative sample of 8028 adult Finns, lung function was measured by spirometry. Information on respiratory diseases and symptoms was collected. Smoking was quantified with serum cotinine levels. Psychotic disorders were diagnosed utilising the Structured Clinical Interview for DSM-IV (SCID-I) and medical records.
RESULTS: Participants with schizophrenia and other non-affective psychoses had significantly lower lung function values compared with the general population, and the association remained significant for schizophrenia after adjustment for smoking and other potential confounders. Schizophrenia was associated with increased odds of pneumonia (odds ratio (OR) = 4.9), chronic obstructive pulmonary disease (COPD, OR = 4.2) and chronic bronchitis (OR = 3.8); and with high cotinine levels.
CONCLUSIONS: Schizophrenia is associated with impaired lung function and increased risk for pneumonia, COPD and chronic bronchitis. © The Royal College of Psychiatrists 2015.

Entities:  

Mesh:

Year:  2015        PMID: 25858177     DOI: 10.1192/bjp.bp.113.141937

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  16 in total

1.  Benzodiazepines and risk of pneumonia in schizophrenia: a nationwide case-control study.

Authors:  Sheng-Yun Cheng; Wen-Yin Chen; Hsing-Cheng Liu; Tien-Wei Yang; Chun-Hung Pan; Shu-Yu Yang; Chian-Jue Kuo
Journal:  Psychopharmacology (Berl)       Date:  2018-09-19       Impact factor: 4.530

2.  Development of a biomarker database toward performing disease classification and finding disease interrelations.

Authors:  Shaikh Farhad Hossain; Ming Huang; Naoaki Ono; Aki Morita; Shigehiko Kanaya; Md Altaf-Ul-Amin
Journal:  Database (Oxford)       Date:  2021-03-11       Impact factor: 3.451

3.  Pneumonia: host susceptibility and shared genetics with pulmonary function and other traits.

Authors:  M B Khadzhieva; A N Kuzovlev; L E Salnikova
Journal:  Clin Exp Immunol       Date:  2019-10-01       Impact factor: 4.330

4.  Comorbidity of schizophrenia and infection: a population-based cohort study.

Authors:  Philip Rising Nielsen; Thomas Munk Laursen; Esben Agerbo
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-10-19       Impact factor: 4.328

5.  Novel disease associations with schizophrenia genetic risk revealed in ~400,000 UK Biobank participants.

Authors:  Ruyue Zhang; Arvid Sjölander; Alexander Ploner; Donghao Lu; Cynthia M Bulik; Sarah E Bergen
Journal:  Mol Psychiatry       Date:  2021-11-19       Impact factor: 13.437

6.  Peer-Based Education Regarding the COVID-19 Pandemic.

Authors:  Patrick W Corrigan; Katherine Nieweglowski
Journal:  J Psychosoc Rehabil Ment Health       Date:  2020-07-09

7.  Excess Mortality and Life-Years Lost in People With Schizophrenia and Other Non-affective Psychoses: An 11-Year Population-Based Cohort Study.

Authors:  Nicholas Chak Lam Yung; Corine Sau Man Wong; Joe Kwun Nam Chan; Eric Yu Hai Chen; Wing Chung Chang
Journal:  Schizophr Bull       Date:  2021-03-16       Impact factor: 9.306

8.  Prevalence of smoking in a psychiatric hospital and its relationship with respiratory symptoms and the prevalence of COPD.

Authors:  Luis Lores; Alfonso Monje; Manel Bergada; Elisabeth Arellano; Julian Rodríguez-Larrea; Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-09-07

9.  A Role for the Transcription Factor Nk2 Homeobox 1 in Schizophrenia: Convergent Evidence from Animal and Human Studies.

Authors:  Eva A Malt; Katalin Juhasz; Ulrik F Malt; Thomas Naumann
Journal:  Front Behav Neurosci       Date:  2016-03-30       Impact factor: 3.558

Review 10.  Schizophrenia and COVID-19: risks and recommendations.

Authors:  Lais Fonseca; Elton Diniz; Guilherme Mendonça; Fernando Malinowski; Jair Mari; Ary Gadelha
Journal:  Braz J Psychiatry       Date:  2020-04-09       Impact factor: 2.697

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.